LYEL - Financial Reports List - Lyell Immunopharma, Inc. - IntrinsicAlpha

Lyell Immunopharma, Inc. LYEL

Healthcare - Biotechnology - NASDAQ - US

$ 0.46

0.946 %

$ 136 M

Market Cap

-0.33

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	-15.38%	-262.62%	-236.20%
Annual Report	FY	10-K	2024-12-31	-53.08%	-46.18%	98.66%
Quarterly Report	Q3	8-K	2024-09-30	36.00%	12.33%	14.45%
Quarterly Report	Q2	8-K	2024-06-30	-51.85%	28.30%	19.13%
Quarterly Report	Q1	8-K	2024-03-31	-95.38%	54.26%	10.26%
Quarterly Report	Q4	8-K	2023-12-31	-73.13%	-2170.50%	-712416.37%
Annual Report	FY	10-K	2023-12-31	-99.85%	-4835.46%	-34.89%
Quarterly Report	Q3	8-K	2023-09-30	733.33%	31.35%	11.14%
Quarterly Report	Q2	8-K	2023-06-30	-99.92%	-75.89%	-76.87%
Quarterly Report	Q1	8-K	2023-03-31	-88.25%	-95.87%	8.78%

1